| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $112.7M | -5.1% |
| SG&A Expense | $50.7M | -7.6% |
| Operating Income | -$163.4M | +5.9% |
| Interest Expense | $22.7M | +15.4% |
| Pre-tax Income | -$182.0M | +5.0% |
| Income Tax | $0 | — |
| Net Income | $47.4M | -75.6% |
| EPS (Basic) | $0.76 | -75.6% |
| EPS (Diluted) | $0.76 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.0M | -89.1% |
| Short-term Investments | $183.9M | +225.7% |
| Accounts Receivable | $213.2M | +458.8% |
| Current Assets | $443.2M | +78.8% |
| Total Assets | $591.0M | +41.0% |
| Current Liabilities | $136.4M | +163.3% |
| Long-term Debt | $315.3M | +0.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$86.5M | +21.2% |
| Capital Expenditures | $113K | -59.2% |
| Investing Cash Flow | -$127.6M | -165.9% |
| Financing Cash Flow | $124.2M | +1866.3% |
| Free Cash Flow | -$86.6M | +21.3% |
| -75.6% |
| Stockholders' Equity |
| $85.7M |
| +260.3% |